X-linked ADGRG2 gene mutation has been verified to be associated with CAVD in recent years and is responsible for approximately 20% of CAVD not related to CFTR mutation (Patat et al., 2016; Bieth et al., 2021). This evidence concerns the gene ADGRG2 and congenital bilateral aplasia of vas deferens from CFTR mutation.